Gujarat Themis Biosyn Ltd

Announcement Under Reg 30 (LODR) - Updates (Audited Financial Statements)

Please refer to our Announcement under Reg 30 (LODR) - Updates (Audited Financial Statements - F.Y. 2025-26)

Company Update / General View filing →

Board Meeting Outcome for Outcome Of Board Meeting Related To QIP

Please refer to the attachment

Others / Outcome without intimation View filing →

Analyst / Investor Meet - Outcome

Please refer to our submission of Call Recordings of the investor/analyst Conference Call held on Monday, August 10, 2026 (IST).

Company Update / Analyst / Investor Meet View filing →

Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel

Insider Trading / SAST / Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 View filing →

Analyst / Investor Meet - Intimation

Please refer to the concall invite to discuss the 1QFY27 Financial performance.

Company Update / Analyst / Investor Meet View filing →

Board Meeting Intimation for Approval Of Un-Audited Financial Results And Limited Review Report Of Statutory Auditor For The Quarter Ended 30.06.2026

Gujarat Themis Biosyn Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the Un-Audited Financial ....

Board Meeting / Board Meeting View filing →

Notice Of Extra-Ordinary General Meeting On 22.08.2026

Please refer to the attachment.

AGM/EGM / EGM View filing →

Newspaper Publication

Please refer to our copies of Newspaper Publication dated 24.07.2026 for Postal Ballot.

Company Update / Newspaper Publication View filing →

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Please refer to the Notice of Postal Ballot 22.07.2026

AGM/EGM / Postal Ballot View filing →

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Pharmaceutical ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Themis Medicare Ltd

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Pharmaceutical ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Pharmaceutical Business ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Themis Medicare Ltd

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

Updates on revised Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

The Exchange has received the updates on revised disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) ....

Insider Trading / SAST / Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 View filing →